PERSPECTIVE THERAPEUTICS, INC. Shares Outstanding (Cover Page)
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Shares Outstanding (Cover Page) of 114.15 million shares as of 2026-08-05, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-05: Entity Common Stock, Shares Outstanding 114.15M shares.
- 2026-05-06: Entity Common Stock, Shares Outstanding 114.05M shares.
- 2026-03-12: Entity Common Stock, Shares Outstanding 113.93M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 74.34M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-05 | 114.15M shares 10-Q · filed 2026-08-10 |
| 2026-05-06 | 114.05M shares 10-Q · filed 2026-05-11 |
| 2026-03-12 | 113.93M shares 10-K · filed 2026-03-16 |
| 2025-11-06 | 74.34M shares 10-Q · filed 2025-11-10 |
| 2025-08-11 | 74.26M shares 10-Q · filed 2025-08-13 |
| 2025-05-07 | 74.23M shares 10-Q · filed 2025-05-12 |
| 2025-03-21 | 74.05M shares 10-K/A · filed 2025-03-28 |
| 2024-11-07 | 67.59M shares 10-Q · filed 2024-11-12 |
| 2024-08-07 | 67.43M shares 10-Q · filed 2024-08-13 |
| 2024-05-10 | 622.63M shares 10-Q · filed 2024-05-15 |
| 2024-03-22 | 586.92M shares 10-K · filed 2024-03-28 |
| 2023-11-10 | 280.57M shares 10-Q · filed 2023-11-14 |
| 2023-08-09 | 280.57M shares 10-Q · filed 2023-08-11 |
| 2023-05-12 | 280.13M shares 10-Q · filed 2023-05-15 |
| 2023-04-27 | 279.97M shares 10-KT · filed 2023-05-01 |
| 2022-11-10 | 142.11M shares 10-Q · filed 2022-11-14 |
| 2022-09-23 | 142.11M shares 10-K · filed 2022-09-28 |
| 2022-05-09 | 142.04M shares 10-Q · filed 2022-05-13 |
| 2022-02-07 | 142.04M shares 10-Q · filed 2022-02-09 |
| 2021-11-09 | 141.92M shares 10-Q · filed 2021-11-10 |
| 2021-09-23 | 141.92M shares 10-K · filed 2021-09-27 |
| 2021-05-12 | 141.47M shares 10-Q · filed 2021-05-14 |
| 2021-02-08 | 141.20M shares 10-Q · filed 2021-02-09 |
| 2020-11-11 | 87.23M shares 10-Q · filed 2020-11-13 |
| 2020-09-21 | 68.90M shares 10-K · filed 2020-09-25 |
| 2020-05-11 | 67.65M shares 10-Q · filed 2020-05-13 |
| 2020-02-11 | 67.65M shares 10-Q · filed 2020-02-12 |
| 2019-11-11 | 67.39M shares 10-Q · filed 2019-11-13 |
| 2019-09-24 | 67.39M shares 10-K · filed 2019-09-27 |
| 2019-05-08 | 67.34M shares 10-Q · filed 2019-05-10 |
| 2019-02-11 | 67.33M shares 10-Q · filed 2019-02-13 |
| 2018-11-09 | 67.33M shares 10-Q · filed 2018-11-09 |
| 2018-09-24 | 67.33M shares 10-K · filed 2018-09-26 |
| 2018-05-02 | 55.10M shares 10-Q · filed 2018-05-04 |
| 2018-02-07 | 55.10M shares 10-Q · filed 2018-02-09 |
| 2017-11-10 | 55.02M shares 10-Q · filed 2017-11-14 |
| 2017-09-25 | 55.02M shares 10-K · filed 2017-09-28 |
| 2017-05-10 | 55.02M shares 10-Q · filed 2017-05-10 |
| 2017-02-07 | 55.02M shares 10-Q · filed 2017-02-09 |
| 2016-11-04 | 55.02M shares 10-Q · filed 2016-11-09 |
| 2016-09-01 | 55.01M shares 10-K · filed 2016-09-09 |
| 2016-05-06 | 55.01M shares 10-Q · filed 2016-05-10 |
| 2016-02-08 | 55.01M shares 10-Q · filed 2016-02-09 |
| 2015-10-19 | 55.01M shares 10-Q · filed 2015-11-09 |
| 2015-09-11 | 55.01M shares 10-K · filed 2015-09-14 |
| 2015-05-08 | 54.91M shares 10-Q · filed 2015-05-15 |
| 2015-02-11 | 54.88M shares 10-Q · filed 2015-02-17 |
| 2014-11-12 | 54.87M shares 10-Q · filed 2014-11-14 |
| 2014-09-26 | 54.88M shares 10-K · filed 2014-09-29 |
| 2014-05-07 | 54.39M shares 10-Q · filed 2014-05-15 |
| 2014-02-06 | 41.54M shares 10-Q · filed 2014-02-14 |
| 2013-11-06 | 38.42M shares 10-Q · filed 2013-11-14 |
| 2013-09-27 | 38.42M shares 10-K · filed 2013-09-30 |
| 2013-05-01 | 34.61M shares 10-Q · filed 2013-05-15 |
| 2013-02-06 | 34.61M shares 10-Q · filed 2013-02-14 |
| 2012-11-06 | 34.60M shares 10-Q · filed 2012-11-14 |
| 2012-09-25 | 34.58M shares 10-K/A · filed 2012-10-26 |
| 2012-05-04 | 29.32M shares 10-Q · filed 2012-05-15 |
| 2012-02-03 | 29.32M shares 10-Q · filed 2012-02-14 |
| 2011-11-07 | 28.99M shares 10-Q/A · filed 2011-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |